Gumerlock P H, Tang Y J, Weiss J B, Silva J
Department of Internal Medicine, University of California, Davis Medical Center, Sacramento 95817.
J Clin Microbiol. 1993 Mar;31(3):507-11. doi: 10.1128/jcm.31.3.507-511.1993.
Clostridium difficile is the infectious agent responsible for antibiotic-associated colitis. We report the use of the polymerase chain reaction technique to identify toxigenic strains of C. difficile in human stool specimens. A set of primers based on the nucleotide sequence of the toxin B gene, which amplified a 399-bp fragment from isolates producing toxin B, was designed. We examined 28 known toxigenic strains, which were all positive by this assay. DNAs from the nontoxigenic strains examined and from strains of Clostridium sordellii and C. bifermentans were not amplified with these primers. The sensitivity of this assay allowed us to identify as little as 10% toxigenic C. difficile cells in the presence of 90% nontoxigenic cells and to detect the toxin B gene in 1 pg of DNA from a toxigenic strain. DNAs extracted from 18 clinical stool specimens that were positive for toxin B by the tissue culture cytotoxicity assay were also positive by this assay. In addition, we detected toxin B sequences in DNA from 2 of 18 stool specimens that were negative for toxin B by the cytotoxicity assay. These two stool specimens were from patients who had a clinical pattern of colitis that was compatible with C. difficile causation. This rapid, sensitive assay will be useful for specific identification of toxigenic C. difficile and for revealing cases that are undetected by analysis of fecal samples for toxin B alone.
艰难梭菌是抗生素相关性结肠炎的致病病原体。我们报告了使用聚合酶链反应技术来鉴定人类粪便标本中艰难梭菌的产毒菌株。基于毒素B基因的核苷酸序列设计了一组引物,该引物能从产生毒素B的分离株中扩增出一个399 bp的片段。我们检测了28株已知的产毒菌株,通过该检测方法它们均呈阳性。所检测的非产毒菌株以及索氏梭菌和双发酵梭菌菌株的DNA,用这些引物未扩增出产物。该检测方法的灵敏度使我们能够在存在90%非产毒细胞的情况下鉴定出低至10%的产毒艰难梭菌细胞,并能从产毒菌株的1 pg DNA中检测到毒素B基因。通过组织培养细胞毒性试验检测毒素B呈阳性的18份临床粪便标本提取的DNA,经该检测方法也呈阳性。此外,我们在细胞毒性试验中毒素B呈阴性的18份粪便标本中的2份标本的DNA中检测到了毒素B序列。这两份粪便标本来自临床结肠炎症状与艰难梭菌致病相符的患者。这种快速、灵敏的检测方法将有助于产毒艰难梭菌的特异性鉴定,以及揭示仅通过粪便样本毒素B分析未检测到的病例。